CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol. 2016;22(4):439-442.   Published online 2016 December 25    DOI: https://doi.org/10.3350/cmh.2016.0108

Excel Download

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clinical and Molecular Hepatology. 2016;22(4):439-442   Crossref logo
Link1 Link2 Link3
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clinical and Molecular Hepatology. 2015;21(3):242   Crossref logo
Link1 Link2 Link3
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clinical and Molecular Hepatology. 2016;22(2):241-249   Crossref logo
Link1 Link2 Link3
Lamivudine plus Adefovir or Telbivudine plus Adefovir for Chronic Hepatitis B Patients with Suboptimal Response to Adefovir
En-Qiang Chen, Tao-You Zhou, Lang Bai, Jing-Rong Wang, Li-Bo Yan, Ling-Bo Liang, Hong Tang
Antiviral Therapy. 2012;17(6):973-979   Crossref logo
Link1 Link2
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clinical and Molecular Hepatology. 2016;22(4):443-449   Crossref logo
Link1 Link2 Link3
Tenofovir Disoproxil Fumarate Monotherapy is Superior to Entecavir-Adefovir Combination Therapy in Patients with Suboptimal Response to Lamivudine-Adefovir Therapy for Nucleoside-Resistant HBV: A 96-Week Prospective Multicentre Trial
Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim, Baek Gyu Jun, Young Don Kim, Dae Won Jun, Joo Hyun Sohn, Tae Yeob Kim, Byung Seok Lee
Antiviral Therapy. 2017;23(3):219-227   Crossref logo
Link1 Link2
36 Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB)
Journal of Hepatology. 2005;42:17   Crossref logo
Link1 Link2
Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures
Qian Zhang, Tao Han, Cai-Yun Nie, Fu-Shuang Ha, Lei Liu, Hua Liu
Journal of Medical Virology. 2015;87(6):1013-1021   Crossref logo
Link1 Link2
Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance
Hyo Jung Cho, Soon Sun Kim, Sung Jae Shin, Byung Moo Yoo, Sung Won Cho, Jae Youn Cheong
Journal of Medical Virology. 2015;87(9):1532-1538   Crossref logo
Link1 Link2
Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis
Rui Huang, Yingying Hao, Jun Zhang, Chao Wu
Hepatology Research. 2013;n/a-n/a   Crossref logo
Link1 Link2
This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.